Friday, August 7, 2020

- Or -

Home In Play

In Play

    These stocks could be In Play. Add them to your watch list.

    Latest

    Xalles Holdings Inc. (XALL) Growing Through Synergistic Acquisitions

    admin -
    Xalles Holdings (OTC: XALL), a financial technology holdings company, led by CEO Thomas Nash, has been the poster child for future CEO’s to...

    STAT News’ Adam Feuerstein Uses Up His Nine Lives on CytoDyn (OTCQB: CYDY)

    admin -
    The feline has attacked CytoDyn Inc. (OTCMKTS: CYDY) nine times within the last 8 months in an...

    Misleading Headline on CydoDyn (CYDY) Triggers Algo Selling

    admin -
    Top short seller Andrew Left from Citron Research facilitated a bear raid led by Tim Sykes and his army of smaller short sellers, and eventually Adam...

    Momentum in Auto Stocks Driving IoT and App Business Like iGEN Network Corporation (IGEN)...

    admin -
    Auto stocks are back in focus, thanks to the momentum in names such as Nikola Corp (NASDAQ: NKLA), Hertz Global (NYSE: HTZ) and Tesla...

    Adam Feuerstein’s Fishing Expedition on CytoDyn (CYDY) Continues to Cast an Empty Net

    admin -
    Instead of reporting on the great advancements that CytoDyn Inc. (OTCMKTS: CYDY) has just announced the completion of  enrollment in its first randomized clinical...

    Post-Pandemic Investment Ideas Like iQSTEL (IQST) Sometime Start out in Small Packages

    admin -
    Miami, FL – June 5, 2020 (Emerging Growth NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history...

    ARCA Biopharma (NASDAQ: ABIO) Nearly Quintuples in Price on Very Speculative COVID-19 Therapy

    admin -
    ARCA Biopharma (NASDAQ: ABIO) had a great trading day based on news that it was going to repurpose one of its existing...

    Sorrento Therapeutics (NASDAQ: SRNE) COVID Cure – FACT or FICTION

    admin -
    Animal model use for target identification not as a predictor of efficacyCOVID-SHIELD or remdesivir would not be very effective against ARDSShorts cry...
    Galectin Therapeutics, Inc. (NASDAQ: GALT) Most Feared Biotech Analyst Losing Relevance as Investor’s Crave Substance over Cyber Bullying

    STAT Reporter Triples Down on CytoDyn (OTCQB: CYDY) Rhetoric with Failed Cyber Bullying...

    admin -
    Miami, FL – May 8, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of...

    CytoDyn (OTCQB: CYDY) Experiencing Viral Boom in Enrollment May Lead to a Presidential Podium...

    admin -
    Miami, FL – March 23, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...
    123...10Page 1 of 10

    STAY CONNECTED

    148,656FansLike
    1,106FollowersFollow
    1,583FollowersFollow
    354SubscribersSubscribe

    Latest News

    © Copyright 2016-2020 - EmergingGrowth.com -- Images via Shutterstock -- Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. Data delayed 15 minutes unless indicated. Electronic EG content as further described in our disclosure (link on the bottom of every page) is for informational purposes only and does not reflect the opinions of EmergingGrowth.com or any of its affiliates. All viewers of EmergingGrowth.com content a. understand and agree that such content does not represent trading or investment advice, and b. agree that they will not hold EmergingGrowth.com or any of its affiliates or subsidiaries liable for any loss or damage caused by your reliance on information contained within.